News

Published on 24 Jan 2025 on Columbia University News

Study Unveils Key Immune Cells Found to Boost Cancer Treatment Success in Acute...


Article preview image

New York, NY—January 24, 2025— A research team from Columbia Engineering and the Irving Institute...

NASDAQ.MAYS price evolution
NASDAQ.AMGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
4 Healthcare Stocks Poised to Crush Q4 Earnings Estimates

Rising patient volumes, technological advancements, rate hikes and other factors are likely to ha...

Zacks · via Yahoo Finance 31 Jan 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75% By...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75%

Investing.com 31 Jan 2025

Is Amgen Inc. (AMGN) a Cheap Quarterly Dividend Stock to Invest In?

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this articl...

Insider Monkey · via Yahoo Finance 31 Jan 2025

Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress...

Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress

Investing.com 30 Jan 2025

Is Regeneron Pharmaceuticals (REGN) Among the Best Depressed Stocks to Invest in...

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 28 Jan 2025

Study Unveils Key Immune Cells Found to Boost Cancer Treatment Success in Acute...

New York, NY—January 24, 2025— A research team from Columbia Engineering and the Irving Institute...

Columbia University News 24 Jan 2025

Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Falling Stock to Invest in...

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, w...

Insider Monkey · via Yahoo Finance 24 Jan 2025

Amgen's SWOT analysis: stock poised for growth amid obesity drug potential By...

According to InvestingPro data, the company maintains a "GOOD" overall financial health score,...

Investing.com 23 Jan 2025

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty...

However, last year, Novartis AG (NYSE:NVS) decided to step back from pursuing the Cytokinetics de...

Benzinga · via Yahoo Finance 22 Jan 2025

Amgen Inc. (AMGN): A Bull Case Theory

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus ...

Insider Monkey · via Yahoo Finance 20 Jan 2025